Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT01478360
Eligibility Criteria:
Inclusion Criteria:
* Adult patients with asthma \>1 year duration diagnosed according to the GINA guidelines (GINA 2010).
* Daily treatment with \> 1000μg beclomethasone dipropionate or equivalent, plus a long acting beta agonist for ≥ 3 months prior to Day 1, that has been stable for at least 4 weeks prior to screening.
* Asthma which is not adequately controlled on current treatment
* Peripheral blood eosinophil count \< 400/μl at screening
Exclusion Criteria:
* Women of child-bearing potential unwilling to use effective contraception during the study and for 16 weeks after stopping treatment.
* Use of other investigational drugs at the time of screening, or within 30 days of screening.
* Smokers
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01478360
Study Brief:
Protocol Section:
NCT01478360